Larimar Therapeutics LRMR
NASDAQ LRMR
$2.35 +0.08 (+3.52%)
At close: Oct 23, 2026 · 4:00 PM EDT

Larimar Therapeutics (LRMR) Sale and Maturity of Investments (2015 - 2025)

Updated

Analysis

Larimar Therapeutics (LRMR) Sale and Maturity of Investments (2015 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Larimar Therapeutics 244.12 Mn -362.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 34.00 Mn
Sep 30, 2025 36.50 Mn
Jun 30, 2025 46.50 Mn
Mar 31, 2025 67.00 Mn
Dec 31, 2024 116.00 Mn
Sep 30, 2024 100.00 Mn
Jun 30, 2024 18.50 Mn
Mar 31, 2024 16.50 Mn
Dec 31, 2023 32.50 Mn
Sep 30, 2023 9.99 Mn
Jun 30, 2023 9,000.00
Mar 31, 2023 92.25 Mn
Dec 31, 2022 19.75 Mn
Dec 31, 2021 6.50 Mn
Jun 30, 2021 19.25 Mn
Mar 31, 2021 7.00 Mn
Mar 31, 2020 20.53 Mn
Dec 31, 2019 7.55 Mn
Sep 30, 2019 25.85 Mn
Jun 30, 2019 41.79 Mn
API Access

Larimar Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=LRMR&period=max&api_key=YOUR_API_KEY